In vivo administration of the frog skin peptide frenatin 2.1S induces immunostimulatory phenotypes of mouse mononuclear cells

Immunology and Microbiology

• Mononuclear Cell 100%
• Macrophage 100%
• Anura 100%
• Peptides 100%
• Natural Killer T Cell 66%
• T Cell 66%
• Peritoneal Cavity 66%
• CD11c 66%
• Immunosuppressive Drug 33%
• MHC Class II 33%
• Inflammation Response 33%
• Tumor Necrosis Factor 33%
• B Cell 33%
• Host Resistance 33%
• Cytokine Production 33%
• Interleukin-1 33%
• Antimicrobial Peptides 33%
• Skin Secretion 33%
• Hylidae 33%
• Chemokine Receptor CXCR3 33%
• CD19 33%
• CD5 33%
• CD69 33%
• Microorganism 33%
• Lymphocyte 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Anura 100%
• Intraperitoneal Injection 33%
• Polypeptide Antibiotic Agent 33%
• Lipopolysaccharide 33%
• Immunosuppressive Agent 33%
• Chemokine Receptor CXCR3 33%
• Cell Receptor 33%
• Malignant Neoplasm 33%
• Tumor Necrosis Factor 33%
• Cytokine 33%
• Inflammation 33%
• Hylidae 33%
• Microorganism 33%
• Diseases 33%

Veterinary Science and Veterinary Medicine

• Mouse 100%
• Macrophage 75%
• Peritoneal Cavity 50%
• Natural Killer T Cell 50%
• T Cell 50%
• B Cell 25%
• Lymphocyte 25%
• Cancer 25%
• Peritoneum 25%